Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

A patient with HAIR-AN syndrome, PCOS, and Hashimoto's thyroiditis improved with early diagnosis and treatment to prevent serious health problems.

Hyperandrogenism and insulin resistance in PCOS-like rats can lead to pregnancy complications due to increased cell death in the uterus and placenta.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Wnt/β-catenin activators can help regrow hair lost due to diabetes.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Metformin helps manage PCOS by improving metabolism and ovulation, but should be part of a personalized treatment plan.

High glucocorticoids cause pancreatic malfunction and malabsorption, reversible with enzyme supplements.

Darkened knuckles can be an early sign of insulin resistance.

CTP-543 is generally safe for treating alopecia areata.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

The FDA did not approve a testosterone drug because of safety concerns.

Combining genetic and physical trait analysis improves diagnosis accuracy for monogenic diabetes.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

CNGA3, GLUD1, and SIRT1 are promising targets for treating aging and glioblastoma.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Early diagnosis and treatment of endocrine disorders like HAIR-AN syndrome can improve outcomes in adolescents.

Enhanced stem cells from the placenta can reduce fat buildup in eye tissue for Graves' disease.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.